Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    20490332 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting First in Man Study Investigating the Biodistribution, the Safety and Optimal Recommended Dose of a New Radiolabelled Monoclonal Antibody Targeting Frizzled Homolog 10
Condition: Sarcoma, Synovial
Interventions: Drug: OTSA101-DTPA-90Y level 1;   Drug: OTSA101-DTPA-90Y level 2;   Drug: OTSA101-DTPA-90Y level 3

Study has passed its completion date and status has not been verified in more than two years.